Rony Dahan

3.5k total citations · 2 hit papers
26 papers, 2.1k citations indexed

About

Rony Dahan is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Oncology. According to data from OpenAlex, Rony Dahan has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Immunology, 13 papers in Radiology, Nuclear Medicine and Imaging and 8 papers in Oncology. Recurrent topics in Rony Dahan's work include Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (10 papers). Rony Dahan is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (13 papers), T-cell and B-cell Immunology (11 papers) and Immunotherapy and Immune Responses (10 papers). Rony Dahan collaborates with scholars based in Israel, United States and Sweden. Rony Dahan's co-authors include Jeffrey V. Ravetch, Stylianos Bournazos, Taia T. Wang, Jad Maamary, Alan J. Korman, Emanuela Sega, Mark Selby, John Engelhardt, Fubin Li and Andrew Pincetic and has published in prestigious journals such as Cell, Proceedings of the National Academy of Sciences and Nature Medicine.

In The Last Decade

Rony Dahan

26 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis

2016 441 citations Anna‐Maria Georgoudaki, Vanessa F. Boura et al. Cell Reports profile →
Bispecific dendritic-T cell engager potentiates anti-tumor immunity

2024 53 citations Ran Salomon, Eitan Winter et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Rony Dahan Israel	19	1.4k	771	618	587	151	26	2.1k
Ignacio Moraga United States	22	1.3k 0.9×	957 1.2×	680 1.1×	360 0.6×	76 0.5×	34	2.2k
Torsten Dreier Belgium	22	1.0k 0.7×	994 1.3×	964 1.6×	1.3k 2.2×	150 1.0×	38	2.6k
Loren D. Erickson United States	26	1.7k 1.2×	472 0.6×	514 0.8×	327 0.6×	97 0.6×	41	2.5k
Achim Rothe Germany	21	693 0.5×	763 1.0×	469 0.8×	476 0.8×	58 0.4×	41	1.7k
Ralph Mocikat Germany	21	1.5k 1.0×	825 1.1×	788 1.3×	463 0.8×	38 0.3×	65	2.3k
Raffaella Meazza Italy	32	2.5k 1.7×	1.1k 1.4×	572 0.9×	267 0.5×	149 1.0×	70	3.2k
Ascensión López-Dı́az de Cerio Spain	22	1.5k 1.0×	917 1.2×	740 1.2×	274 0.5×	81 0.5×	43	2.4k
Cleo Goyvaerts Belgium	23	821 0.6×	648 0.8×	646 1.0×	269 0.5×	71 0.5×	48	1.4k
John O. Richards United States	16	638 0.4×	477 0.6×	423 0.7×	370 0.6×	63 0.4×	32	1.4k
Arnob Banerjee United States	22	2.0k 1.4×	1.2k 1.5×	959 1.6×	225 0.4×	62 0.4×	66	3.1k

Countries citing papers authored by Rony Dahan

Since Specialization

Citations

This map shows the geographic impact of Rony Dahan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rony Dahan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rony Dahan more than expected).

Fields of papers citing papers by Rony Dahan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rony Dahan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rony Dahan. The network helps show where Rony Dahan may publish in the future.

Co-authorship network of co-authors of Rony Dahan

This figure shows the co-authorship network connecting the top 25 collaborators of Rony Dahan. A scholar is included among the top collaborators of Rony Dahan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rony Dahan. Rony Dahan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Dahan, Rony & Alan J. Korman. (2024). Fc-optimized checkpoint antibodies for cancer immunotherapy. Trends in Molecular Medicine. 31(6). 501–505. 1 indexed citations

Yalin, Adam, Tomer Landsberger, Ran Salomon, et al.. (2023). Fc glycoengineering of a PD-L1 antibody harnesses Fcγ receptors for increased antitumor efficacy. Science Immunology. 8(81). eadd8005–eadd8005. 28 indexed citations

Knorr, David A., Lucas Blanchard, Rom S. Leidner, et al.. (2023). FcγRIIB Is an Immune Checkpoint Limiting the Activity of Treg-Targeting Antibodies in the Tumor Microenvironment. Cancer Immunology Research. 12(3). 322–333. 18 indexed citations

Salomon, Ran, Yonatan Katzenelenbogen, Assaf Weiner, et al.. (2022). Bispecific antibodies increase the therapeutic window of CD40 agonists through selective dendritic cell targeting. Nature Cancer. 3(3). 287–302. 53 indexed citations

Artzy‐Schnirman, Arbel, Enas Abu‐Shah, Rona Chandrawati, et al.. (2022). Artificial Antigen Presenting Cells for Detection and Desensitization of Autoreactive T cells Associated with Type 1 Diabetes. Nano Letters. 22(11). 4376–4382. 2 indexed citations

Salomon, Ran & Rony Dahan. (2022). Next Generation CD40 Agonistic Antibodies for Cancer Immunotherapy. Frontiers in Immunology. 13. 940674–940674. 42 indexed citations

Furth, Noa, Adina Weinberger, Amiel A. Dror, et al.. (2021). Unified platform for genetic and serological detection of COVID-19 with single-molecule technology. PLoS ONE. 16(7). e0255096–e0255096. 2 indexed citations

Li, Hao, Bingting Ma, Daniele Bendayan, et al.. (2021). Human antibodies targeting a Mycobacterium transporter protein mediate protection against tuberculosis. Nature Communications. 12(1). 602–602. 55 indexed citations

Feferman, Tali, David Morgenstern, Yaniv Lustig, et al.. (2021). Anti-SARS-CoV-2 antibodies elicited by COVID-19 mRNA vaccine exhibit a unique glycosylation pattern. Cell Reports. 37(11). 110114–110114. 33 indexed citations

10.

Yofe, Ido, Rony Dahan, & Ido Amit. (2020). Single-cell genomic approaches for developing the next generation of immunotherapies. Nature Medicine. 26(2). 171–177. 71 indexed citations

11.

Biram, Adi, Anneli Strömberg, Eitan Winter, et al.. (2019). BCR affinity differentially regulates colonization of the subepithelial dome and infiltration into germinal centers within Peyer’s patches. Nature Immunology. 20(4). 482–492. 40 indexed citations

12.

Dahan, Rony, Bryan C. Barnhart, Fubin Li, et al.. (2016). Therapeutic Activity of Agonistic, Human Anti-CD40 Monoclonal Antibodies Requires Selective FcγR Engagement. Cancer Cell. 29(6). 820–831. 128 indexed citations

13.

Georgoudaki, Anna‐Maria, Vanessa F. Boura, Eva Hellqvist, et al.. (2016). Reprogramming Tumor-Associated Macrophages by Antibody Targeting Inhibits Cancer Progression and Metastasis. Cell Reports. 15(9). 2000–2011. 441 indexed citations breakdown →

14.

Dahan, Rony, Emanuela Sega, John Engelhardt, et al.. (2015). FcγRs Modulate the Anti-tumor Activity of Antibodies Targeting the PD-1/PD-L1 Axis. Cancer Cell. 28(3). 285–295. 288 indexed citations

15.

Pincetic, Andrew, Stylianos Bournazos, David J. DiLillo, et al.. (2014). Type I and type II Fc receptors regulate innate and adaptive immunity. Nature Immunology. 15(8). 707–716. 365 indexed citations

16.

Dahan, Rony, John A. Gebe, Anton Preisinger, et al.. (2013). Antigen-specific immunomodulation for type 1 diabetes by novel recombinant antibodies directed against diabetes-associates auto-reactive T cell epitope. Journal of Autoimmunity. 47. 83–93. 14 indexed citations

17.

Vandenbark, Arthur A., Roberto Meza‐Romero, Gil Benedek, et al.. (2012). A novel regulatory pathway for autoimmune disease: Binding of partial MHC class II constructs to monocytes reduces CD74 expression and induces both specific and bystander T-cell tolerance. Journal of Autoimmunity. 40. 96–110. 36 indexed citations

18.

Dahan, Rony, Yuan K. Chou, Roberto Meza‐Romero, et al.. (2011). TCR‐like antibodies distinguish conformational and functional differences in two‐ versus four‐domain auto reactive MHC class II–peptide complexes. European Journal of Immunology. 41(5). 1465–1479. 12 indexed citations

19.

Sinha, Sushmita, Sandhya Subramanian, Thomas M. Proctor, et al.. (2007). A Promising Therapeutic Approach for Multiple Sclerosis: Recombinant T-Cell Receptor Ligands Modulate Experimental Autoimmune Encephalomyelitis by Reducing Interleukin-17 Production and Inhibiting Migration of Encephalitogenic Cells into the CNS. Journal of Neuroscience. 27(46). 12531–12539. 47 indexed citations

20.

Jones, Richard E., Cathleen Rich, Rony Dahan, et al.. (2004). HLA‐DRB1*1501 risk association in multiple sclerosis may not be related to presentation of myelin epitopes. Journal of Neuroscience Research. 78(1). 100–114. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact